Eliot Engel actually said...

U.S. prescription drug spending rose by 41 percent between 2007 and 2017.

Due to the lack of transparency, my constituents often get a pricing surprise when they arrive at their pharmacy.

I agree with that assessment. But the Administration's intention to counter that appears to be through bilateral actions.

I do have some concerns with the Administration's approaches, including the recognition of the fraudulent election outcome in the DRC.